Smilow Cancer Hospital proudly announces a 3-year full reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS), in partnership with Yale Cancer Center, an NCI-Designated Comprehensive Cancer Center. To achieve CoC reaccreditation, compliance with accreditation standards that evaluate cancer care services were assessed during a recent site visit.
Smilow Cancer Hospital and Yale Cancer Center were recognized for applying a multidisciplinary approach and treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other healthcare professionals that specialize in caring for patients with cancer. As noted in the report, patients benefit from having access to clinical trials, screening and prevention expertise, palliative care, genetic counseling, rehabilitation, oncology nutrition, and survivorship services. Also noted was the strong commitment from hospital and health system leadership to providing strategic resources for growth, and attention to the delivery of high-quality care in the region.
Harold Tara, Jr., MD, Assistant Professor of Medicine (Medical Oncology) and Chair of the Cancer Committee, commented, “I want to thank each and every person involved in the survey submission and site visit for their commitment and dedication to the amazing work we do each day. This was truly a team effort that we should all be proud of.”
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons.